Chemoinformaics analysis of Sagequinone-Methide-A
| Molecular Weight | 328.408 | nRot | 1 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 20 |
| Exact Molecular Weight | 328.167 | nRing | 4 |
| Solubility: LogS | -4.452 | nHRing | 1 |
| Solubility: LogP | 4.369 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 52.611 |
| nHD | 1 | BPOL | 27.549 |
| QED | 0.603 |
| Synth | 4.733 |
| Natural Product Likeliness | 1.59 |
| NR-PPAR-gamma | 0.956 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.297 |
| Pgp-sub | 0.142 |
| HIA | 0.126 |
| CACO-2 | -4.976 |
| MDCK | 0.0000291 |
| BBB | 0.331 |
| PPB | 0.985552 |
| VDSS | 1.025 |
| FU | 0.0129345 |
| CYP1A2-inh | 0.084 |
| CYP1A2-sub | 0.812 |
| CYP2c19-inh | 0.549 |
| CYP2c19-sub | 0.914 |
| CYP2c9-inh | 0.754 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.054 |
| CYP2d6-sub | 0.256 |
| CYP3a4-inh | 0.556 |
| CYP3a4-sub | 0.881 |
| CL | 11.282 |
| T12 | 0.508 |
| hERG | 0 |
| Ames | 0.203 |
| ROA | 0.184 |
| SkinSen | 0.538 |
| Carcinogencity | 0.329 |
| EI | 0.86 |
| Respiratory | 0.736 |
| NR-Aromatase | 0.89 |
| Antiviral | Yes |
| Prediction | 0.544574 |